Celldex Therapeutics (CLDX) PT Lowered to $60 at Canaccord
Tweet Send to a Friend
(Updated - July 22, 2026 7:41 AM EDT)
Canaccord analyst Ed Nash lowered the price target on Celldex Therapeutics ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Canaccord analyst Ed Nash lowered the price target on Celldex Therapeutics ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
